ShulmanLab

Investigating Alzheimer's and Parkinson's disease genomics to understand mechanisms of brain aging, and to improve risk prediction, diagnosis and treatments.

[ShulmanLab @LabShulman]

New insights on the relationship between Alzheimer’s disease, aging, immunity, and neuronal vulnerability—check out our new preprint! https://t.co/Ms866jj7Ia

[ShulmanLab @LabShulman]

Is #Parkinson’s one disease or hundreds of different conditions? What is the difference between sporadic and familial disease? What is a “PD gene” really? Can we distill coherent biology? Check out our new @AnnualReviews on Parkinson’s syndrome! https://t.co/lCgYL14lxs

[ShulmanLab @LabShulman]

Amazing visit to the CABD in beautiful Sevilla! Thanks to Lola and Acaimo for inviting / hosting and to all for the stimulating conversations!

[Centro Andaluz de Biología del Desarrollo @CABD_UPO_CSIC]

Today Joshua Shulman @LabShulman from @bcmhouston delivered a great talk about brain transcriptomics involved in aging and Alzheimer’s to the #CABD community! 🧠🪰 Followed by an informal get together with PhD students! Dr. Shulman is being hosted by @mdmarber!

[ShulmanLab @LabShulman]

Congrats Steven!!

[ShulmanLab @LabShulman]

In our latest preprint, we pinpoint 15 lysosomal storage disorder gene modifiers of alpha-synuclein #neurodegeneration, including many known or likely #Parkinsons disease risk genes! https://t.co/azdDkwoX1N

[ShulmanLab @LabShulman]

@BoeynaemsSteven Thanks, can't wait!

[ShulmanLab @LabShulman]

@BoeynaemsSteven @bcmhouston @TexasChildrens We are absolutely thrilled to welcome Steven and the Boeynaems Lab to the Duncan NRI, CAND and BCM--Congrats!!

[ShulmanLab @LabShulman]

Genome sequencing in the Parkinson’s Disease clinic—are we ready yet? Our new preprint grapples with the promise and pitfalls of personalized genomic medicine for PD: https://t.co/RxbGtdj2ND

[ShulmanLab @LabShulman]

Work with outstanding colleagues at the Duncan Neurological Research Institute (https://t.co/hlnwVsNC9H). New Baylor College of Medicine tenure-track/tenured faculty search for neurodegenerative disease research: https://t.co/nD0LS2vziF

[ShulmanLab @LabShulman]

@bcmneurology @bcmhouston Congrats, Adriana!

[ShulmanLab @LabShulman]

@KaczorowskiLab @SinghNeuro Congrats, how awesome!

[ShulmanLab @LabShulman]

Our new Baylor Center for Alzheimer’s and Neurodegenerative Diseases is searching for 3 tenure-track faculty, including basic and clinician-scientists! Join our team: https://t.co/ZSWyInSKC9

[ShulmanLab @LabShulman]

Resolving Parkinson’s disease heterogeneity for precision therapies! New publications highlight the promise of genetics and enhanced motor phenotyping:
https://t.co/CTs7PpDDt6
https://t.co/FRnZfeiiS9

[ShulmanLab @LabShulman]

#Walk2EndAlz #EndAlz @bcmhouston

[ShulmanLab @LabShulman]

An integrated transcriptome-proteome atlas of tauopathy highlights pervasive overlap with brain aging. https://t.co/PJpgRto1LB

[ShulmanLab @LabShulman]

@bess_frost Yay!

[ShulmanLab @LabShulman]

@sudha_md Thanks, Sudha!

[ShulmanLab @LabShulman]

@KaczorowskiLab Thanks!

[ShulmanLab @LabShulman]

Parkinson’s Disease is clinically heterogeneous! Check out our two new manuscripts on (1) how best to quantify motor heterogeneity and (2) the potential contribution of genetic risk factors:
https://t.co/zwfABkONfS
https://t.co/dczHhSosIM

[ShulmanLab @LabShulman]

We are excited to have partnered with Jim Lupski’s group to explore the relative contribution of single nucleotide and copy number variants to Parkinson’s disease risk. Check out our first Neurology Genetics paper to learn the results! https://t.co/nPXaA585mh